[AC/Priv] Underage Reporting and Enforcement - XI/CSI

Internal document

Raw text

Transcribed text as recorded, including headers and formatting fragments.

Case 4:22-md-03047-YGR Document 3012-21 Filed 05/02/26 Page 1 of 3 Exhibit 131 Case 4:22-md-03047-YGR Document 3012-21 Filed 05/02/26 [AC/Priv] Underage Reporting and Enforcement - XI/CSI A/C PRIV-REFLECTS ADVICE OF COUNSEL, ATTORNEY-CLIENT COMMUNICATIONS, AND IS WORK PRODUCT DONE AT THE DIRECTION OF COUNSEL Jointly drafted by Central Social Impact Age Assurance and XI Actor Page 2 of 3 Updated Operating Model (10/2) TL;DR The CSI team has been building context and expertise around Human Review flows and is on a good path to self sufficiency, including currently running an audit of the flows. We are going to adjust our RACI and associated investment approach and move allocated XI Eng capacity (1 IC6 PID) to XI:Authenticity to support S.1 (Enforcement). CSI will formally take accountability/responsibility for human review (measurement, workflows, capacity management). This reflects how the team is already operating today and will minimise dependencies between Orgs. XI:Authenticity will continue to be responsible for the appeal and verification experience. These changes are reflected in the RACI below. ALIGNED: Operating Model Clarity: Underage Enforcement: 3/6, 145pm PT Attendees: Miki Rothschild TLDR: XI own enforcement when someone is reported, CSI will own proactive detection, ensuring consistent experiences and coverage across apps, identification of new appeal methods. Formatted: Font: (Default) Calibri, Not Bold, No underline, Font color. Auto, Highlight Formatted: Font: (Default) Calibri, Not Bold, No underline, Font color: Auto, Highlight Formatted: Font: (Default) Calibri, Not Bold, No underline, Font color: Auto, Highlight Formatted: Font: (Default) Calibri, Not Bold, Highlight Formatted: Font: (Default) Calibri, Not Bold, Highlight Formatted: Font: (Default) Calibri, Not Bold, Highlight Formatted: Font: (Default) Calibri, Highlight Formatted: Font: Not Bold, Highlight Formatted: Highlight Formatted: Font: Not Bold, Highlight Formatted: Highlight Formatted: Highlight Commented [1]: I feel like we are currently doing this? 1 total reaction 1. XI will own: a. When someone is sent for review, XI ensures the review is high quality, and there is infrastructure to support new methods as needed. i. XI will liaise with Kate Gotimer's team on ops capacity XI also: support CSI to build new age verification capabilities on the central authenticity platform to enable re-use of verification capabilities and prevent fragmentation, 2. CSI will own: a. Proactive detection strategic approach + building of any requirements to enforce on proactive detection (e.g. heuristics) b. Identification of gaps across apps - ensuring consistent experiences and coverage c. Will identify new methods for verification and will build those methods d. Will triage any SEVs to the appropriate team, as needed Detailed RACI: Reviewed and aligned by: Miki Rothschild HIGHLY CONFIDENTIAL (COMPETITOR) reacted with at 2024-09-30 08:43 AM Commented [2]: +1, we (CSI) have been driving all the measurement and human review flow work 1 total reaction AM reacted with at 2024-10-02 01:39 Formatted: Highlight Formatted: Highlight Formatted: Font color: Auto, Highlight Formatted: Highlight Formatted: Highlight Formatted: Highlight Formatted: Highlight Formatted: Highlight Formatted: Highlight Deleted: Updated Operating Model (10/2)1 UPDATE (09/26/24) The CSI team has been building context and expertise around Human Review flows and until today has not relied on any support from the XI:Actor team. They are on a way to self sufficiency here. We are going to adjust our RACI and associated investment approach and move allocated Eng capacity (1 IC6 PID) to XI:Authenticity to support 5.1. META3047MDL-294-00159772 Subworkstreams 3. Propagations Case 4:22-md-03047-YGR Document 3012-21 Filed 05/02/26 Responsibilities E2E Monitoring SEV Management Strategy - long term underage enforcement strategy With any decision the following would not shift: 1. Integrity Ops support across the board for both FoA and RL 2. RL Trust and VR Integrity ownership: a. VR Reporting Web Form, E2E Monitoring with identified FB and IG team with v-team approach The triage and reconciliation of SEVs as they arise. Proactive and Reactive short and long term underage enforcement strategy, including identifying and mitigating gaps across FOA/WA and RL. b. Twilight Reporting Experience, c. Headset Reporting Experience d. Salsa checkpoint experiences Page 3 of 3 e. UFAC owns enforcement experience f. Authenticity owns ID appeal jobs 3. WA enforcement remains status quo. 4. SPACE (Signal Propagation and Consistent Enforcement aka Family Experiences Propagation) maintains ownership of propagation of signals. 5. Authenticity ownership of UFAC and AVS 1A. XI Misrep Staffing People Misrep team, owning the Underage E2E reporting and enforcement flow, focuses on impersonation problems, where age plays a relatively minor factor, resulting in an overall lower priority and understaffed on the Underage domain. The Underage reporting and enforcement pipeline had been put to Maintenance Mode the past 1.5yr, with the team only conducting bug/Sev fixes and monitoring. Since then, the majority of eng and XFN with context have departed. The current task force contains: <0.25 Eng, <0.25 DE, 0 PM and other XFN 1B. Historical SEVs Included all Sevs from 2023 related ta the discussed domain. Created Month Start -> Mitigate Sev Number Severity Affected Description / Impact App S395677 Sev 3 February 2024 Unclear on start date IG IG automated policy to ignore above age users has 70-75% precision (comparing to 95%+ goal), resulting in ~30% reports incorrectly ignored. Create to mitigate 4d in February Solved short term by turned off this automation policy. Critic Detected by DS manual audit Goal was not clearly documented until DS manual audit and investigate. No monitoring or alerting were set-up. If happens under proposed RACI, Which team is the owner? CSI HIGHLY CONFIDENTIAL (COMPETITOR) ΜΕΤΑ3047MDL-294-00159779